Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact

Blog

Home Archive by category "Featured Stories"

When Deprived of Nerve Cells, Hydra Rears Compensatory Gene Program

By medicilon | Featured Stories | 0 comment | 26 November, 2015 |

Though tiny, the freshwater Hydra has regenerative abilities more impressive than those of its namesake, the nine-headed monster of Greek legend. Both the real Hydra and the mythical Hydra can undergo morphallaxis—tissue regeneration—when body parts are injured or severed. But the real Hydra has an extra trick up its sleeve, or down its collar. TheRead more

Microbial Sex Rapidly Disseminates Ecologically Important Genes

By medicilon | Featured Stories | 0 comment | 26 November, 2015 |

    Horizontal gene transfer, the scientific moniker for bacterial sex, is a fundamental part of microbial evolution, as it allows key genetic loci, such as antibiotic resistance, to spread through diverse microbial communities. However, since the event is relatively infrequent, scientists have often wondered why gene transfer events have been able to exert such strong effects.Read more

New ‘Intelligent’ Gel Directly Attacks Cancer

By medicilon | Featured Stories | 0 comment | 25 November, 2015 |

    Scientists have developed a new injectable ‘biogel’ that can effectively deliver anti-cancer agents directly into cancerous tumours and kill them.  The technology, developed by researchers at the University of Montreal Hospital Research Centre (CRCHUM), has already been successfully tested in the laboratory.  The injectable biogel is liquid at room temperature and solidifies at 37°C—human bodyRead more

Novel Nanocarriers Open Door to Better Treatment for Brain Cancer

By medicilon | Featured Stories | 0 comment | 25 November, 2015 |

    A researcher at Lawrence Berkeley National Laboratory thinks she might have found a solution to transporting therapeutics across the blood-brain barrier to treat a deadly form of brain cancer. Ting Xu, Ph.D., a polymer scientist, who specializes in self-assembling bio/nano hybrid materials, has developed a new family of nanocarriers formed from the self-assembly of amphiphilicRead more

New Antibiotic Resistance Gene That Breaches ‘Last Line of Defense’ Is Found

By medicilon | Featured Stories | 0 comment | 23 November, 2015 |

    A new gene has been discovered that allows bacteria to become resistant to our last line of antibiotic defense. The gene, MCR-1, was found to be widespread in pigs and patients in south China, with some strains having epidemic potential.  MCR-1 was found to enable bacteria to become resistant to polymyxins; the colistin and polymyxinRead more

Single Gene Found to Play Huge Role in Brain Development

By medicilon | Featured Stories | 0 comment | 23 November, 2015 |

    Researchers at the Institute of Molecular Biology (IMB) in Mainz, Germany say they have unraveled a complex regulatory mechanism that explains how a single gene can drive the formation of brain cells. Their study (“NeuroD1 reprograms chromatin and transcription factor landscapes to induce the neuronal program”), published in The EMBO Journal, is an important stepRead more

RNA-Based Drugs Give More Control Over Gene Editing

By medicilon | Featured Stories | 0 comment | 23 November, 2015 |

In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego SchoolRead more

Nano Sensor Measures MicroRNAs Could Speed Up Cancer Detection

By medicilon | Featured Stories | 0 comment | 23 November, 2015 |

    The role of microRNAs in the detection of various types of cancer has become increasingly evident over the past several years. However, a major drawback of using these molecules as a diagnostic indicator of disease has been developing a method that is sensitive enough to detect minuscule amounts of the genetic material in a timeframeRead more

Novel Therapeutics Show Promise for Treating Persistent Tuberculosis

By medicilon | Featured Stories | 0 comment | 20 November, 2015 |

    Researchers from the Florida campus of the Scripps Research Institute (TSRI) say they have discovered several first-in-class compounds that target inactive Mycobacterium tuberculosis bacteria that hide inside cell aggregates, latent and persistent, waiting to break out. The researchers described a technique in ACS Chemical Biology (“First-in-Class Inhibitors of Sulfur Metabolism with Bactericidal Activity against Non-ReplicatingRead more

Researchers Discover Novel Cancer Immunotherapy Target

By medicilon | Featured Stories | 0 comment | 20 November, 2015 |

    Scientists from the Institut de recherches cliniques de Montreal (IRCM) led by André Veillette, M.D., have identified the mechanism of action for a new target for novel immune-oncology treatments. Their discovery (“DNAM-1 controls NK cell activation via an ITT-like motif”) is described in the Journal of Experimental Medicine.     The researchers study natural killer (NK) cells,Read more

205206207208209

About Us

  • Medicilon Overview
  • Executive Team
  • Company History
  • CEO Message
  • Honor
  • Customer Reviews
  • New Models of Collaboration
  • Intellectual Property Protection
  • Corporate Culture
  • Careers
  • Download Center
  • Contact

Share

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.

Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved Privacy Policy
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact
Medicilon Inc